糖尿病技术进步对生活质量的影响:解决吸收障碍

IF 0.5 Q4 ENDOCRINOLOGY & METABOLISM Practical Diabetes Pub Date : 2023-09-01 DOI:10.1002/pdi.2476

Anne Kilvert, Charles Fox

{"title":"糖尿病技术进步对生活质量的影响:解决吸收障碍","authors":"Anne Kilvert, Charles Fox","doi":"10.1002/pdi.2476","DOIUrl":null,"url":null,"abstract":"Abstract One hundred years after insulin was first used to treat diabetes, technology is advancing rapidly, with insulin pumps and continuous glucose monitoring devices established in clinical care. Hybrid closed loop systems have been successfully piloted in the UK and the National Institute for Health and Care Excellence is developing a guideline for access for people with type 1 diabetes. Initial studies of diabetes technology focused on glycaemic benefits, but many now include measures of quality of life/person reported outcome measures and diabetes‐specific and technology‐specific questionnaires have been validated. Focus groups and semi‐structured interviews can add insights to the personal experience. The quality of life evidence for technology is positive overall, but for some people the burdens of technology outweigh the benefits and create barriers to uptake. Health care professionals have a pivotal role in exploring individual barriers and priorities, managing expectations and providing education and support to help people achieve quality of life benefits as well as enhanced glycaemic control. They should take care to ensure equality of access for all by avoiding personal bias. Developers of the technology should involve stakeholders to ensure their needs are met. Copyright © 2023 John Wiley & Sons.","PeriodicalId":20309,"journal":{"name":"Practical Diabetes","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The impact of diabetes technology advances on quality of life: addressing the barriers to uptake\",\"authors\":\"Anne Kilvert, Charles Fox\",\"doi\":\"10.1002/pdi.2476\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract One hundred years after insulin was first used to treat diabetes, technology is advancing rapidly, with insulin pumps and continuous glucose monitoring devices established in clinical care. Hybrid closed loop systems have been successfully piloted in the UK and the National Institute for Health and Care Excellence is developing a guideline for access for people with type 1 diabetes. Initial studies of diabetes technology focused on glycaemic benefits, but many now include measures of quality of life/person reported outcome measures and diabetes‐specific and technology‐specific questionnaires have been validated. Focus groups and semi‐structured interviews can add insights to the personal experience. The quality of life evidence for technology is positive overall, but for some people the burdens of technology outweigh the benefits and create barriers to uptake. Health care professionals have a pivotal role in exploring individual barriers and priorities, managing expectations and providing education and support to help people achieve quality of life benefits as well as enhanced glycaemic control. They should take care to ensure equality of access for all by avoiding personal bias. Developers of the technology should involve stakeholders to ensure their needs are met. Copyright © 2023 John Wiley & Sons.\",\"PeriodicalId\":20309,\"journal\":{\"name\":\"Practical Diabetes\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Practical Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pdi.2476\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Practical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pdi.2476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 1

摘要

胰岛素首次用于治疗糖尿病一百多年后，技术发展迅速，胰岛素泵和连续血糖监测装置在临床护理中建立起来。混合闭环系统已经在英国成功试点，国家健康和护理卓越研究所正在制定1型糖尿病患者获取指南。最初对糖尿病技术的研究侧重于降糖益处，但现在许多研究包括生活质量测量/人员报告结果测量以及糖尿病特异性和技术特异性问卷调查已得到验证。焦点小组和半结构化访谈可以增加对个人经验的见解。总的来说，技术对生活质量的影响是积极的，但对一些人来说，技术的负担超过了好处，并造成了接受技术的障碍。卫生保健专业人员在探索个人障碍和优先事项，管理期望以及提供教育和支持以帮助人们获得生活质量益处以及加强血糖控制方面发挥着关键作用。他们应该注意避免个人偏见，确保所有人都能平等获得教育。该技术的开发人员应该让利益相关者参与进来，以确保满足他们的需求。版权所有©2023 John Wiley &儿子。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The impact of diabetes technology advances on quality of life: addressing the barriers to uptake

Abstract One hundred years after insulin was first used to treat diabetes, technology is advancing rapidly, with insulin pumps and continuous glucose monitoring devices established in clinical care. Hybrid closed loop systems have been successfully piloted in the UK and the National Institute for Health and Care Excellence is developing a guideline for access for people with type 1 diabetes. Initial studies of diabetes technology focused on glycaemic benefits, but many now include measures of quality of life/person reported outcome measures and diabetes‐specific and technology‐specific questionnaires have been validated. Focus groups and semi‐structured interviews can add insights to the personal experience. The quality of life evidence for technology is positive overall, but for some people the burdens of technology outweigh the benefits and create barriers to uptake. Health care professionals have a pivotal role in exploring individual barriers and priorities, managing expectations and providing education and support to help people achieve quality of life benefits as well as enhanced glycaemic control. They should take care to ensure equality of access for all by avoiding personal bias. Developers of the technology should involve stakeholders to ensure their needs are met. Copyright © 2023 John Wiley & Sons.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Practical Diabetes ENDOCRINOLOGY & METABOLISM-

CiteScore

1.10

自引率

16.70%

发文量

期刊介绍： Practical Diabetes concerns itself with all aspects of the worldwide clinical science and practice of diabetes medicine. The journal recognises the importance of each member of the healthcare team in the delivery of diabetes care, and reflects this diversity of professional interest in its editorial contents. The Editors welcome original papers, case reports, practice points, audit articles and letters on any aspect of clinical diabetes care from any part of the world. The journal also publishes commissioned leaders, review articles and educational and training series, for which an honorarium normally is paid. All articles submitted to Practical Diabetes are independently peer reviewed. They must not have been published or be under submission currently elsewhere. Enquiries from prospective authors are welcomed and the Editors will be pleased, if asked, to advise on preparation and submission of articles. All articles and enquiries should be directed to the Editors at the publishing address below. The journal is published nine times a year, and currently the average waiting time for acceptance of articles is eight weeks, and for subsequent publication sixteen weeks. Practical Diabetes is independent of any commercial or vested interest.